Related Experiment Video
Updated: Aug 17, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms
1Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Abstract:
Hedgehog pathway overactivity has been implicated in the development of a variety of human cancers. The Human Hedgehog interacting protein (HHIP), a negative regulator of hedgehog signaling, has been shown to be underexpressed in pancreatic cancers. In this study we determined if the HHIP gene is a target for genetic and epigenetic alterations. While no mutations of HHIP were identified, we found complete methylation of the HHIP promoter CpG island in three pancreatic cancer cell lines, and partial hypermethylation in 13/17 (80%) pancreatic cancer cell lines, 35/75 (46%) primary pancreatic cancers and 14/18 (78%) pancreatic cancer xenografts, but no methylation in 13 normal pancreata. In pancreatic cancer cell lines, complete methylation was associated with absent or reduced HHIP expression by real-time RT-PCR. HHIP expression could be restored in methylated cell lines using epigenetic modifier drugs. Restoring the expression of HHIP in pancreatic cancer cells by 5-aza-2'-deoxycytidine led to a decrease in Gli reporter activity, consistent with downregulation of Hedgehog signaling. These results indicate in some pancreatic adenocarcinomas that HHIP is epigenetically inactivated by promoter methylation, and its silencing could contribute to the increased Hedgehog signaling observed in pancreatic neoplasms.
Insights
Human Hedgehog interacting protein (HHIP) is silenced by promoter methylation in pancreatic cancer, contributing to aberrant hedgehog signaling. Epigenetic drugs can restore HHIP expression, offering potential therapeutic strategies for pancreatic neoplasms.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Aberrant hedgehog signaling is a hallmark of various human cancers.
- Human Hedgehog interacting protein (HHIP) negatively regulates hedgehog signaling and is underexpressed in pancreatic cancers.
Purpose of the Study:
- To investigate genetic and epigenetic alterations of the HHIP gene in pancreatic cancer.
- To determine the role of HHIP inactivation in pancreatic cancer pathogenesis.
Main Methods:
- Analysis of HHIP gene mutations and promoter CpG island methylation in pancreatic cancer cell lines, primary tumors, and xenografts.
- Assessment of HHIP expression using real-time RT-PCR.
- Treatment of cell lines with epigenetic modifier drugs to restore HHIP expression.
- Evaluation of hedgehog signaling activity via Gli reporter assays.
Main Results:
- No mutations in the HHIP gene were found.
- Complete or partial promoter methylation of HHIP was detected in a significant proportion of pancreatic cancer cell lines (80%), primary cancers (46%), and xenografts (78%), but not in normal pancreata.
- Methylation correlated with reduced or absent HHIP expression.
- Epigenetic drug treatment restored HHIP expression and decreased hedgehog signaling activity.
Conclusions:
- Epigenetic inactivation of HHIP via promoter methylation is a mechanism contributing to hedgehog pathway overactivity in pancreatic adenocarcinomas.
- Restoration of HHIP expression by epigenetic therapy may represent a therapeutic approach for pancreatic cancer.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

